These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8849843)
1. Effects of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment. Haerian A; Adonogianaki E; Mooney J; Manos A; Kinane DF J Clin Periodontol; 1996 Feb; 23(2):83-91. PubMed ID: 8849843 [TBL] [Abstract][Full Text] [Related]
2. Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. Haerian A; Adonogianaki E; Mooney J; Docherty JP; Kinane DF J Clin Periodontol; 1995 Jul; 22(7):505-9. PubMed ID: 7560232 [TBL] [Abstract][Full Text] [Related]
3. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Tüter G; Kurtiş B; Serdar M J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249 [TBL] [Abstract][Full Text] [Related]
4. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid. Pourtaghi N; Radvar M; Mooney J; Kinane DF J Periodontol; 1996 Sep; 67(9):866-70. PubMed ID: 8884643 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892 [TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Nomura T; Ishii A; Oishi Y; Kohma H; Hara K Oral Dis; 1998 Dec; 4(4):231-40. PubMed ID: 10200701 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658 [TBL] [Abstract][Full Text] [Related]
8. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. Leppilahti JM; Kallio MA; Tervahartiala T; Sorsa T; Mäntylä P J Periodontol; 2014 Feb; 85(2):250-60. PubMed ID: 23659421 [TBL] [Abstract][Full Text] [Related]
9. The utility of gingival crevicular fluid matrix metalloproteinase-8 response patterns in prediction of site-level clinical treatment outcome. Leppilahti JM; Sorsa T; Kallio MA; Tervahartiala T; Emingil G; Han B; Mäntylä P J Periodontol; 2015 Jun; 86(6):777-87. PubMed ID: 25741578 [TBL] [Abstract][Full Text] [Related]
12. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. Tüter G; Serdar M; Kurtiş B; Walker SG; Atak A; Toyman U; Pinar S; Aykan T J Periodontol; 2010 Aug; 81(8):1132-9. PubMed ID: 20370419 [TBL] [Abstract][Full Text] [Related]
13. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. Hernández M; Gamonal J; Tervahartiala T; Mäntylä P; Rivera O; Dezerega A; Dutzan N; Sorsa T J Periodontol; 2010 Nov; 81(11):1644-52. PubMed ID: 20653434 [TBL] [Abstract][Full Text] [Related]
14. Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients. Pawar DD; Mehta DS J Investig Clin Dent; 2015 May; 6(2):118-24. PubMed ID: 24357595 [TBL] [Abstract][Full Text] [Related]
15. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). Okuda K; Miyazaki A; Momose M; Murata M; Nomura T; Kubota T; Wolff LF; Yoshie H J Periodontal Res; 2001 Oct; 36(5):309-16. PubMed ID: 11585118 [TBL] [Abstract][Full Text] [Related]
16. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190 [TBL] [Abstract][Full Text] [Related]
17. Effect of locally delivered minocycline microspheres on markers of bone resorption. Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491 [TBL] [Abstract][Full Text] [Related]
18. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy. Emingil G; Han B; Gürkan A; Berdeli A; Tervahartiala T; Salo T; Pussinen PJ; Köse T; Atilla G; Sorsa T J Periodontol; 2014 Aug; 85(8):1070-80. PubMed ID: 24283658 [TBL] [Abstract][Full Text] [Related]
20. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. Nakamura T; Kido J; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T J Periodontol; 2000 Mar; 71(3):361-7. PubMed ID: 10776922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]